Pathogenic bacteria are considered to be one of the biggest threats to global health in the future of mankind. Continuous population growth, increasing mobility, the growing number of foodborne illnesses and emerging resistance of bacteria against current antibiotic treatments are multiple challenges which urgently require breakthrough ideas and innovations in more rapid pathogen detection solutions to be brought to the marketplace.
NEMIS Technologies is developing diagnostic kits and solutions for accelerated microbiological detection in food safety, hospital and clinical applications and water treatment with the potential to set new market standards. NEMIS’ core AquaSpark™ technology allows faster, highly specific, efficacious, easy-to-handle and cost-efficient diagnostic tests.
The technology enables highly sensitive chemiluminescence probes for research and diagnostic applications: the AquaSpark™ molecules are 3,000 times brighter than standard commercially available products. This is leading to much faster time-to-results for diagnostic kits incorporating the technology thus reducing effectively important safety risks.